Get the Stockscreener App
0.00
100.00%
-0.1973
Carmell Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.
See More
Previous Close:
$0.1973
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$5.94M
Revenue:
-
Net Income/Loss:
$-11.11M
P/E Ratio:
0.00
EPS:
-2.4155
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.00
Carmell Corp Stock (CTCX) Company Profile
Name
Carmell Corp
Sector
Industry
Phone
412-894-8248
Address
2403 SIDNEY STREET, SUITE 300, PITTSBURGH
Compare CTCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTCX
Carmell Corp
|
0.00 | 5.94M | 0 | -11.11M | 0 | -2.4155 |
|
PG
Procter Gamble Co
|
168.57 | 395.27B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.92 | 146.82B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
90.44 | 73.89B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
139.65 | 46.32B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
23.53 | 44.97B | 15.46B | 1.03B | 1.34B | 0.53 |
Carmell Corp Stock (CTCX) Latest News
Carmell Corporation changes name to Longevity Health Holdings - Pennsylvania Business Report
Local biotech company rebrands as Longevity Health Holdings - The Business Journals
CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO - GlobeNewswire
CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY - The Bakersfield Californian
CTCXCarmell Corp Latest Stock News & Market Updates - StockTitan
Carmell Stock Price, Quotes and Forecasts | NASDAQ:CTCX - Benzinga
CTCX stock touches 52-week low at $0.2 amid market challenges - Investing.com
CTCX stock touches 52-week low at $0.2 amid market challenges By Investing.com - Investing.com South Africa
Carmell Corp announces CEO transition, appoints new leader - MSN
Carmell Corp (CTCX) Stock: A Year of Highs and Lows - The InvestChronicle
Market Resilience: Carmell Corp (CTCX) Finishes Weak at 0.32, Down -25.58 - The Dwinnex
Carmell Corp Files For Mixed Shelf Of Up To $100 Million -February 03, 2025 at 05:40 pm EST - Marketscreener.com
Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL
Carmell Closes Purchase of Elevai Skincare - Orange County Business Journal
Carmell Corp announces CEO transition, appoints new leader By Investing.com - Investing.com South Africa
Carmell Corporation Announces CEO Changes -January 24, 2025 at 05:00 pm EST - Marketscreener.com
Carmell Therapeutics Announces Leadership Transition and New CEO - TipRanks
South Side biotech firm Carmell Therapeutics acquires skincare companyPittsburgh Business Times - The Business Journals
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture - Yahoo Finance
Carmell Announces Closing of Elevai Skincare Acquisition - The Manila Times
Carmell Acquires Elevai Skincare in $1.1M Stock Deal, Expanding Beauty Portfolio - StockTitan
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off - MSN
Carmell's earning potential swells with Elevai acquisition - MSN
Carmell Corporation to Acquire Physician-Dispensed Elevai Skincare - BeautyMatter
Nasdaq Surges Over 1%; Cerence Shares Spike Higher - Benzinga
Carmell Closes PIPE Investment from Existing and New Investors - citybiz
Dow Jumps Over 100 Points; ISM Manufacturing PMI Increases In December - Benzinga
Carmell Therapeutics Secures $1.85M Private Placement to Fuel Bio-Aesthetic Growth Strategy - StockTitan
Carmell acquires Elevai Skincare - Fashion Network
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy - GlobeNewswire Inc.
Cardill More Than Doubles On Acquisition - MENAFN.COM
Crude Oil Surges 2%; Tesla Shares Plummet - Benzinga
Carmell To Acquire Elevai Skincare - citybiz
CopperU.S. STOCKS ON THE MOVE-Tesla, Copper Miners, Natgas Firms - eFXdata
Carmell's earning potential swells with Elevai acquisition (CTCX) - Seeking Alpha
Cardill More than Doubles on Acquisition - Baystreet.ca
Wall Street Today: US stocks open higher after markets reopen post New Year; Tesla shares down 7% on low delivery data | Stock Market News - Mint
Carmell Corporation acquires Elevai assets for $1.1M By Investing.com - Investing.com Australia
Carmell Corporation acquires Elevai assets for $1.1M - Investing.com
Carmell Announces Execution of Definitive Agreement to - GlobeNewswire
Carmell Acquires Elevai Skincare's $2.5M Revenue Portfolio, Expanding Bio-Aesthetic Platform - StockTitan
South Side biotech firm Carmell Therapeutics enters into $1.85M private placement offering - The Business Journals
PHLX British Pound (XDB) QuotePress Release - The Globe and Mail
U.S. Dollar Index (DXY) QuotePress Release - The Globe and Mail
TSX Composite Banks Index (TXBA) QuotePress Release - The Globe and Mail
Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday? - Benzinga
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out - The Manila Times
Carmell Therapeutics Raises $1.85M in Private Placement with Potential $3.7M Total Funding - StockTitan
Carmell Corp Stock (CTCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
7.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):